Hi Shemara,
Can you confirm your figure of $150k. ($150,000)
I have quickly re-read the Investor Presentation and found the following on page 22:
Vaxinia CF33 + nHIS
MAST Study Phase 1 - 30 patients
Estimated cost $150/4.5m
MAST Study Phase 2 - 120 Patients
Estimated Cost $150/18m
There was no "k" attached to $150. Did I miss something?
Ann: Appendix 4C - quarterly, page-46
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $382.1K | 7.853M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8072405 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 668099 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |